Related Experiment Video
Updated: May 16, 2026

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate (NMDA) Receptor in Blood
Published on: January 9, 2018
Anti-N-methyl-D-aspartate receptor encephalitis
Sian Y Lim1, Ragesh Panikkath, Charoen Mankongpaisarnrung
1Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas 79430, USA. yik.lim@ttuhsc.edu
Abstract:
A case of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis with an atypical finding of transient increased intracranial pressure is reported. Anti-NMDAR encephalitis is an underrecognized, novel and treatable form of encephalitis being increasingly identified as an explanation of encephalitis in young adults. Management of these patients requires a multidisciplinary approach involving neurologists, internists, nursing and rehabilitation staff. It is important for internists to recognize this condition and consider it in the differential diagnosis of encephalopathy. Internists also need to be familiar with the clinical manifestations and the treatment of the disease as they have an important role in the care of these patients during their prolonged stay in the hospital. Increased intracranial pressure is an atypical and underrecognized finding that has been only noted in a previous review on this disorder. It may present a diagnostic or management challenge in patients with anti-NMDAR encephalitis.
Insights
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a treatable condition often seen in young adults. This case highlights transient increased intracranial pressure as an atypical, underrecognized finding in NMDAR encephalitis management.
Area of Science:
- Neuroimmunology
- Neurology
Background:
- Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an increasingly recognized autoimmune neurological disorder.
- It is a treatable cause of encephalitis, particularly in young adults.
- Diagnosis and management require a multidisciplinary team approach.
Observation:
- This report details a case of anti-NMDAR encephalitis with an unusual presentation.
- The patient exhibited transiently increased intracranial pressure, an atypical finding in this condition.
- Increased intracranial pressure can pose diagnostic and management challenges.
Findings:
- Anti-NMDAR encephalitis is a treatable condition often presenting with psychiatric and neurological symptoms.
- Transient increased intracranial pressure is an underrecognized, atypical manifestation.
- Early recognition by internists is crucial for timely diagnosis and intervention.
Implications:
- Highlights the importance of considering anti-NMDAR encephalitis in the differential diagnosis of encephalopathy.
- Emphasizes the need for internists to be familiar with the clinical spectrum and management of NMDAR encephalitis.
- Suggests that increased intracranial pressure should be recognized as a potential, albeit atypical, feature requiring careful management.
More Related Videos
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
08:20Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis
Published on: June 2, 2022
Related Concept Videos
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Arboviral Encephalitis
Antiepileptic Drugs: Glutamate Antagonists
Viral Meningitis
Bacterial Meningitis I: Introduction